Helius Medical Technologies, a Nasdaq-listed company, has announced plans to adopt Solana (SOL) as its primary reserve asset. The decision follows a successful PIPE deal that raised over $500 million, led by Pantera Capital and Summer Capital, with potential proceeds reaching $1.25 billion. The funds will be used to establish a Solana-based digital asset treasury, reflecting a growing trend of corporate adoption of blockchain technologies. This move aligns Helius Medical with other Nasdaq-listed companies, such as Forward Industries, which have also made significant investments in Solana. The increasing institutional interest in Solana highlights its rising prominence in the blockchain sector.